Skip to search formSkip to main contentSkip to account menu

Zanamivir

Known as: ATC code J05AH01, ATCvet code QJ05AH01, Relenza 
Zanamivir INN /zəˈnæmᵻvɪər/ is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses. It… 
Wikipedia (opens in a new tab)

Related topics

Related topics

1 relation
Computational chemistry

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
A concept sensor-based system to be integrated in an existing automated platform monitoring bacterial growth
Bacterial infections are still one of the main causes of disease around the world. For this reason, the early diagnosis of an… 
Review
2016
Review
2016
THE USE OF ADAPTOGENIC HERBAL PRODUCTS FOR THE CORRECTION OF HEAT AND COLD STRESS ON THE BODY
All patients received the following treatments: • Antiviral therapy in recommended doses (neuraminidase inhibitors Relenza… 
2012
2012
In vitro methods to predict aerosol drug deposition in normal adults
IN VITRO METHODS TO PREDICT AEROSOL DRUG DEPOSITION IN NORMAL ADULTS By Renishkumar R. Delvadia, B. Pharm., M.Pharm. A… 
2010
2010
William Graeme Laver. 3 June 1929 — 26 September 2008
A novel influenza virus of swine origin that emerged in Mexico in April 2009 has spread globally in humans and caused the first… 
2009
2009
UK MHRA sets up webpage for Tamiflu/Relenza adverse event reports
  • 2009
  • Corpus ID: 195168254
2009
2009
Relenza dry powder for inhalation not intended for use in nebulisers or mechanical ventilators
  • 2009
  • Corpus ID: 195167744
2006
2006
Development of an Australian pandemic vaccine
Although influenza pandemics have plagued mankind for centuries, a pandemic resulting from the current H5N1 threat would be a… 
2005
2005
Chemistry in Pasteur's Quadrant
CSIRO (www.csiro.au) is the largest of the publicly funded Australian research agencies. It is focussed on research that benefits… 
2001
2001
NICE and Relenza — the saga continues (2)
2000
2000
Advertisement for Relenza
[Glaxo Wellcome responds:] Deena Ages notes that the patient information pamphlet for Relenza does not include the statement in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)